Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Hydroxyurea to Reduce Stroke Risk in Tanzanian Children with Sickle Cell Anemia

Emmanuela E. Ambrose, MD, Luke R. Smart, MD, Primrose Songoro, RN, Idd Shabani, MD, Protas Komba, MD, Mwesige Charles, BScHLS, Thad A. Howard, MS, Susan E. Stuber, MA, Adam Lane, PhD, Teresa Latham, MA, Abel Nkono Makubi, PhD MD MSc, Russell E. Ware, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-135944

Published: 2020

Journal Articles

FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease

R. Clark Brown, MD PhD, Kimberly Cruz, MD MS, Theodosia A. Kalfa, MD PhD, Frans A. Kuypers, PhD, Santosh L. Saraf, MD, Jeremie H. Estepp, MD, Luke R. Smart, MD, Punam Malik, MD, Mark Lerman, MD, Renae Mayer, MD, Maria D. Ribadeneira, PhD, Sanjeev Forsyth, MS, Patricia Schroeder, PhD, Eric Wu, PhD, Patrick Kelly, MD, Marilyn J. Telen, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-134269

Published: 2020

Journal Articles

Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants

Luke R. Smart, MD, Emmanuela E. Ambrose, MD, Mwesige Charles, BScHLS, Arielle G. Hernandez, MPH, Teresa S. Latham, MA, Adolfine Hokororo, MD MMed, MSc, Medard Beyanga, BLS, MSc, Erasmus Kamugisha, MD MSc, PhD, Erius Tebuka, MD MMed, Thad A. Howard, MS, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 988.

https://doi.org/10.1182/blood-2019-128554

Published: 2019

Journal Articles

Geospatial Mapping of Sickle Cell Disease in Northwest Tanzania: The Tanzania Sickle Surveillance Study (TS3)

Emmanuela E. Ambrose, MD, Luke R. Smart, MD, Mwesige Charles, BScHLS, Arielle G. Hernandez, MPH, Adolfine Hokororo, MD MMed, MSc, Teresa Latham, MA, Medard Beyanga, BLS, MSc, Erius Tebuka, MD MMed, Erasmus Kamugisha, MD MSc, PhD, Thad A. Howard, MS, Russell E. Ware, MD PhD

Blood (2018) 132 (Supplement 1): 3662.

https://doi.org/10.1182/blood-2018-99-113939

Published: 2018

Journal Articles

A Simple, Rapid, and Inexpensive Color-Based Hemoglobin Assay As a Robust Screening Test for Severe Anemia in Limited Resource Settings

Marina Perez-Plazola, Erika Tyburski, BS, Luke R. Smart, MD, Thad A. Howard, MS, Sophie Perier, BS MS, Russell E. Ware, MD PhD, Wilbur A Lam, MD PhD, Patrick T. McGann, MD

Blood (2018) 132 (Supplement 1): 4724.

https://doi.org/10.1182/blood-2018-99-112898

Published: 2018

Journal Articles

Simultaneous Point-of-Care Detection of Anemia and Sickle Cell Disease in Tanzania: The RAPID Study

Luke R. Smart, MD, Emmanuela E. Ambrose, MD MMed, Kevin C. Raphael, MD, Adolfine Hokororo, MD MMed, MSc, Erica A. Tyburski, MS, Wilbur A. Lam, MDPhD, Russell E. Ware, MD PhD, Patrick T. McGann, MD MS

Blood (2017) 130 (Supplement 1): 762.

https://doi.org/10.1182/blood.V130.Suppl_1.762.762

Published: 2017

NARROW

Hydroxyurea to Reduce Stroke Risk in Tanzanian Children with Sickle Cell Anemia

FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease

Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants

Geospatial Mapping of Sickle Cell Disease in Northwest Tanzania: The Tanzania Sickle Surveillance Study (TS3)

A Simple, Rapid, and Inexpensive Color-Based Hemoglobin Assay As a Robust Screening Test for Severe Anemia in Limited Resource Settings

Simultaneous Point-of-Care Detection of Anemia and Sickle Cell Disease in Tanzania: The RAPID Study

Email alerts

ASH Publications

American Society of Hematology

Hydroxyurea to Reduce Stroke Risk in Tanzanian Children with Sickle Cell Anemia

FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease

Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants

Geospatial Mapping of Sickle Cell Disease in Northwest Tanzania: The Tanzania Sickle Surveillance Study (TS3)

A Simple, Rapid, and Inexpensive Color-Based Hemoglobin Assay As a Robust Screening Test for Severe Anemia in Limited Resource Settings

Simultaneous Point-of-Care Detection of Anemia and Sickle Cell Disease in Tanzania: The RAPID Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only